The independent source for health policy research, polling, and news.
59,901 - 59,920 of 112,168 Results
Health and Human Services Secretary Kathleen Sebelius visited Oregon Tuesday, where state officials - unlike their counterparts in many capitals around the country - broadly back the health overhaul plan.
An effort to streamline the entangled field of Medicare drug plans could mean as many as 3 million seniors will have to switch plans next year - often unexpectedly - an analysis by Avalere Health finds.
Opinions today cover topics ranging from the controversial court decision on stem cell research to a commentary by current and former U.S. drug enforcement officials on whether Californians should say "no" to legalizing pot.
"A month ahead of the 2010 Millennium Development Goals (MDGs) review summit at the United Nations, some women's groups are voicing concern that member states' commitment to women's issues is insufficient and slowing progress towards gender parity worldwide," Inter Press Service reports in an article that examines progress towards reaching women-centered MDGs.
As companies look forward to a bright future in some areas of health technology-namely, electronic medical records-other parts of the med-tech industry are watching sales slip.
The Washington Times continues its coverage of the challenges facing the U.S. Millennium Challenge Corporation (MCC)
Part of the previously planned $7.5 billion U.S. aid package for Pakistan will be redirected to flood rebuilding projects, said USAID Administrator Rajiv Shah, the Associated Press reports. Shah also "warned that other nations would only contribute money if Islamabad could ensure it would be well spent."
Prescription drug abuse soars despite the creation of drug monitoring programs already running in 33 states.
European drugmakers face "patent expiries, tougher regulation and burdensome health care reforms," The Wall Street Journal reports.
States address a range of health policy issues.
The National Insitutes of Health suspends the funding of new embryonic stem cell research following after federal court Monday ordered the government to stop funding the projects because the work involves destructions of embryos.
Today's early morning highlights from the major news organizations, including reports about a Medicare change that may cause an estimated three million seniors to switch their drug coverage.
In a bid to rally support among doctors for the health overhaul, a White House official underscored both sticks and carrots the federal government is offering the health industry.
The health law will require insurers to cover routine care for patients in clinical trials, but it may leave brokers on a limb.
Today's opinions question the wisdom of Rep. Paul Ryan's Roadmap, fret rising worker's compensation premiums and raise questions about health overhaul given Massachusetts' experiment.
States address a range of health care policy issues.
"A law intended to speed up development of new drugs for U.S. kids has ended up financing clinical trials in poor countries, where the medicines might never become available," suggest the authors of a study published online Monday in the journal Pedatrics, Reuters reports (Joelving, 8/23).
© 2026 KFF